Genetic predispositions that impair this mechanism in favor of the synapse-suppressing Aβ, such as ApoE4 genotype and mutations in APP or the presenilins, which release Aβ from APP, lead to an imbalance of Aβ levels and initiate AD pathogenesis. Here, APP is linked to Alzheimer disease.